↓ Skip to main content

Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trial

Overview of attention for article published in BMC Cancer, February 2016
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
82 Dimensions

Readers on

mendeley
71 Mendeley